Skip to content

Wigard Kloosterman

Cyclomics appoints advisory board

Cyclomics is pleased to announce that it has established its advisory board to help the company to shape its strategy for continued growth and development. The advisory board is chaired by Joris Schuurmans, a seasoned executive with long-standing experience in molecular cancer diagnostics, currently serving as Chief Development Officer at SkylineDx, and is furthermore comprised of experienced members with valuable… Read More »Cyclomics appoints advisory board